本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

再鼎醫藥

32.53
+2.829.49%
盤後32.20-0.3300-1.01%16:49 EDT
成交量:122.14萬
成交額:3,928.19萬
市值:35.66億
市盈率:-12.52
高:32.70
開:31.83
低:31.13
收:29.71
資料載入中...
2024/04/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/17

SEC問詢函

Form CORRESP - Correspondence
2024/02/09

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/08

重要事件披露

Form 8-K - Current report
2024/02/08

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/01

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/01

SEC問詢函

Form CORRESP - Correspondence
2024/01/06

SEC問詢函

Form CORRESP - Correspondence
2024/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/22

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2023/12/04

SEC問詢函

Form CORRESP - Correspondence
2023/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]